Pharmaceutical Manufacturing Market by Drug Development Type, Formulation, Therapy Area, Route of Administration, Prescription, Age Group, Distribution Channels

Description

List of Tables

The Global Pharmaceutical Manufacturing Market is forecasted to grow significantly, with a projected USD 572.30 billion in 2023 at a CAGR of 12.47% and expected to reach a staggering USD 1,304.53 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Pharmaceutical Manufacturing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Pharmaceutical Manufacturing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Drug Development Type, market is studied across In-House and Outsource. The In-House is projected to witness significant market share during forecast period.

Based on Formulation, market is studied across Capsules, Injectable, Powders, Sprays, Suspensions, and Tablets. The Capsules is projected to witness significant market share during forecast period.

Based on Therapy Area, market is studied across Cancer, Cardiovascular Diseases, Diabetes, Pain, and Respiratory Diseases. The Cancer is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across Inhalations, Oral, Parenteral, and Topical. The Inhalations is projected to witness significant market share during forecast period.

Based on Prescription, market is studied across Over-the-Counter (OTC) Medicines and Prescription Medicines. The Prescription Medicines is projected to witness significant market share during forecast period.

Based on Age Group, market is studied across Adults, Children & Adolescents, and Geriatric. The Geriatric is projected to witness significant market share during forecast period.

Based on Distribution Channels, market is studied across Non-Retail and Retail. The Non-Retail is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Pharmaceutical Manufacturing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharmaceutical Manufacturing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Manufacturing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Manufacturing Market?

4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Manufacturing Market?

5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Manufacturing Market?

6. What is the market share of the leading vendors in the Global Pharmaceutical Manufacturing Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Manufacturing Market?

Product Code: MRR-8760467A9DE8

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pharmaceutical Manufacturing Market, by Drug Development Type, 2022 vs 2030
4.3. Pharmaceutical Manufacturing Market, by Formulation, 2022 vs 2030
4.4. Pharmaceutical Manufacturing Market, by Therapy Area, 2022 vs 2030
4.5. Pharmaceutical Manufacturing Market, by Route of Administration, 2022 vs 2030
4.6. Pharmaceutical Manufacturing Market, by Prescription, 2022 vs 2030
4.7. Pharmaceutical Manufacturing Market, by Age Group, 2022 vs 2030
4.8. Pharmaceutical Manufacturing Market, by Distribution Channels, 2022 vs 2030
4.9. Pharmaceutical Manufacturing Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in global demand for vaccines and drugs
  - 5.1.1.2. Growing pharmaceutical R&D spending
  - 5.1.1.3. Growth in geriatric population and incidence rate of chronic disorders
- 5.1.2. Restraints
  - 5.1.2.1. Complexities associated with the production
- 5.1.3. Opportunities
  - 5.1.3.1. Rise in the investment and funding programs in pharmaceutical manufacturing sector
  - 5.1.3.2. Emergence in the advancements of pharmaceutical manufacturing technologies
- 5.1.4. Challenges
  - 5.1.4.1. Logistics complexities and limited skilled professionals
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. Pharmaceutical Manufacturing Market, by Drug Development Type

6.1. Introduction
6.2. In-House
6.3. Outsource

7. Pharmaceutical Manufacturing Market, by Formulation

7.1. Introduction
7.2. Capsules
7.3. Injectable
7.4. Powders
7.5. Sprays
7.6. Suspensions
7.7. Tablets

8. Pharmaceutical Manufacturing Market, by Therapy Area

8.1. Introduction
8.2. Cancer
8.3. Cardiovascular Diseases
8.4. Diabetes
8.5. Pain
8.6. Respiratory Diseases

9. Pharmaceutical Manufacturing Market, by Route of Administration

9.1. Introduction
9.2. Inhalations
9.3. Oral
9.4. Parenteral
9.5. Topical

10. Pharmaceutical Manufacturing Market, by Prescription

10.1. Introduction
10.2. Over-the-Counter (OTC) Medicines
10.3. Prescription Medicines

11. Pharmaceutical Manufacturing Market, by Age Group

11.1. Introduction
11.2. Adults
11.3. Children & Adolescents
11.4. Geriatric

12. Pharmaceutical Manufacturing Market, by Distribution Channels

12.1. Introduction
12.2. Non-Retail
12.3. Retail

13. Americas Pharmaceutical Manufacturing Market

13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States

14. Asia-Pacific Pharmaceutical Manufacturing Market

14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam

15. Europe, Middle East & Africa Pharmaceutical Manufacturing Market

15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom

16. Competitive Landscape

16.1. FPNV Positioning Matrix
16.2. Market Share Analysis, By Key Player
16.3. Competitive Scenario Analysis, By Key Player

17. List of Company Mentioned

18. Appendix

18.1. Discussion Guide
18.2. License & Pricing

1. Actiza Pharmaceutical Pvt. Ltd.

2. Aenova Group GmbH

3. AstraZeneca PLC

4. Bayer AG

5. Boehringer Ingelheim Group

6. Bristol-Myers Squibb

7. Cipla Limited

8. Eli Lilly and Company

9. F. Hoffmann-La Roche AG

10. F. Hoffmann-La Roche Ltd.

11. Famar SA

12. GlaxoSmithKline PLC

13. Johnson & Johnson Private Limited

14. Lonza Group AG

15. Merck & Co., Inc.

16. Novartis AG

17. Novo Nordisk A/S

18. Pfizer, Inc.

19. Piramal Pharma Solutions

20. Recipharm AB

21. Sanofi S.A.

22. Sun Pharmaceutical Industries Limited